Flixotide And Pavtide Accuhalers
GSK Australia is correcting certain batches of Flixotide and Pavtide Accuhalers because some devices may fail to automatically load the next dose. The affected Accuhalers are distributed across Australia. This is a Class I correction, meaning the devices may not work as intended.
- Reason
- GlaxoSmithKline (GSK) Australia Pty Ltd is issuing a product correction for certain batches of their Flixotide and Pavtide Accuhalers as a small number of Accuhalers may not automatically reload the next dose.
- Classification
- Class I
- Category
- drug recall
- Country
- Australia
- Agency
- Therapeutic Goods Administration
- Recall date
- 2026-04-15
- Status
- Ongoing
- Distribution
- Australia-wide
Official recall notice from Therapeutic Goods Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/c7fd2c3a-962e-46bd-9c61-48b0c67d93a5